חוב לטווח קצר להון Thermo Fisher Scientific (TMO)

The "razor-and-blade" model, characterized by the sale of expensive systems and perpetual consumables, contrasts with the aggressive acquisition of new assets for Thermo Fisher Scientific (TMO). The ratio of short-term debt to equity reconciles these approaches, while 0.02 marks a new level of this financial maturity. Ultimately, the diversification of services and equipment for pharma giants guarantees Thermo Fisher Scientific (TMO) exceptional resilience and a steady cash flow.

Assess the financial stability of Thermo Fisher Scientific (TMO) through the lens of short-term liabilities. This ratio compares loans maturing within one year to equity, revealing the balance sheet's dependence on operational borrowing. When analyzing the historical short-term accounts payable to equity ratio, note the value 0.02. For this laboratory equipment behemoth with a high share of recurring payments, this indicator confirms the ability to fund M&A transactions without risking a loss of liquidity.